| Food Products Industry | Consumer Staples Sector | Mr. Jung-Bae Lim CEO | KRX SM Exchange | KR7001681006 ISIN |
| South Korea Country | 5,046 Employees | 30 Mar 2026 Last Dividend | 27 Mar 2007 Last Split | - IPO Date |
Daesang Corporation Preferred shares represent a unique investment opportunity within the food and bio industries. These shares offer investors fixed dividend payments, positioning them above common stockholders in the payout hierarchy and appealing to those looking for consistent income. Daesang, a South Korean conglomerate, has established itself as a significant player across various sectors, including health, wellness, and nutrition. The company’s preferred shares combine the stability of bonds with the growth potential of equity, making them a crucial part of a diversified investment portfolio. Daesang’s reputation for innovation and quality in its product offerings enhances the attractiveness of its preferred shares, especially for investors focused on steady, reliable returns from the dynamic fields of food production and biotechnology.
Daesang provides a wide range of food ingredients, including natural sweeteners, flavor enhancers, and preservation agents, to support the food industry. These high-quality ingredients are crucial for manufacturers looking to improve the taste, texture, and longevity of their products, helping them meet consumer demands for both delicious and nutritious options.
The corporation offers an extensive selection of processed foods, spanning from ready-to-eat meals to fermented products such as kimchi. This category caters to the growing consumer preference for convenience without compromising on health and flavor, leveraging Daesang’s expertise in food technology and innovative packaging solutions.
Amino acids are vital for human health, functioning as the building blocks of proteins. Daesang's production of amino acids, geared towards both nutritional supplements and pharmaceutical applications, underscores its commitment to supporting wellness at the cellular level. Its products are designed to enhance dietary supplements and provide critical components for medical treatments.
Daesang's foray into pharmaceuticals includes the development and manufacturing of drugs that address a range of health issues. By leveraging its biotechnological expertise, the company contributes to the advancement of healthcare solutions, offering products that ensure better health outcomes and improve the quality of life for individuals worldwide.